2m 2m 2m 2m 2m 2m 2m
Geron (GERN)
NASDAQ
$1.53+$0.005 (+0.33%)
Price as of Aug 21, 2026 7:30 PM EDT- $976.6MMarket Cap
- 4.11%1-Year Change
- BiotechnologyIndustry
Geron (GERN)
$1.53+$0.005 (+0.33%)
GERN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.52 | ||
Change | -$0.03 (-1.94%) | ||
Open | $1.56 | ||
High | $1.57 | ||
Low | $1.50 | ||
Previous Close | $1.55 | ||
Volume | 4,433,381 | ||
30-Day Average Volume | 10,546,066 | ||
1-Week Change | 3.40% | ||
1-Month Change | 5.56% | ||
1-Year Change | 4.11% | ||
3-Year Change | -42.21% | ||
5-Year Change | 19.69% | ||
Fundamentals | |||
Shares Outstanding | 642.5M | ||
Total Assets | $519.0M | ||
Market Cap | $976.6M | ||
Enterprise Value | $1.0B | ||
Period: QTR TTM FY | |||
Revenue | $57.5M | ||
Net Income | -$16.7M | ||
Free Cash Flow | -$15.8M | ||
EBIT | -$12.5M | ||
EBITDA | -$12.3M | ||
Net Working Capital | $416.0M | ||
EPS | -$0.02 | ||
Enterprise Value/EBITDA | -84 | ||
Enterprise Value/Revenue | 18 | ||
P/B | 4 | ||
P/E | -76 | ||
PEG | 1 | ||
Price/Free Cash Flow | -62 | ||
Price/Operating Cash Flow | -62 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue